6 research outputs found

    Libro del XVIII Congreso Nacional de Ciencia y Tecnolog铆a - APANAC 2021

    Get PDF
    Desde su fundaci贸n en 1985, APANAC ha sido clave en promover un espacio de comunicaci贸n y crecimiento para la comunidad cient铆fica en Panam谩, a trav茅s de la promoci贸n de sus logros, as铆 como en la promoci贸n ante el Estado de la necesidad de apoyar el desarrollo de la Ciencia como base para el crecimiento sostenible de nuestra sociedad. As铆 es como hace cerca de 25 a帽os, APANAC juega un papel fundamental en la generaci贸n y promulgaci贸n de la Ley 13 de 1997 con la que se crea SENACYT. Igualmente, dentro de esta misi贸n de desarrollo a la comunidad cient铆fica se ha logrado consolidar el Congreso que hoy se inaugura en su XVIII versi贸n. Este Congreso en particular ha representado un reto muy importante, sobretodo por darse en medio de una pandemia global, con devastadoras consecuencias econ贸micas, que ha puesto de manifiesto las profundas diferencias que aquejan a la sociedad paname帽a. Sin embargo, estas circunstancias, han hecho tambi茅n evidente la importancia de la Ciencia y la Tecnolog铆a, reforzando la necesidad de que las pol铆ticas p煤blicas, planes de Gobierno o bien las respuestas a las crisis, se hagan no s贸lo con base en evidencias cient铆ficas, sino tambi茅n con una perspectiva interdisciplinaria. Es as铆 como este Congreso tiene una relevancia 煤nica, dado que muestra la existencia en nuestro pa铆s de una masa cr铆tica de cient铆ficos y acad茅micos comprometidos en sus diferentes 谩reas de trabajo con el desarrollo de Panam谩. La calidad de las conferencias, mesas redondas y simposios que se presentan en este XVIII Congreso es muestra de ello, sobretodo porque en su gran mayor铆a, son el producto de trabajos nacionales. Agradecemos a la SENACYT, as铆 como a todas las Universidades e Institutos de Investigaci贸n Nacional por su apoyo y activa participaci贸n en este Congreso, a la Ciudad del Saber por su soporte log铆stico y a la Embajada del Estado de Israel en Panam谩 por su gesti贸n en facilitar la participaci贸n de muchos de los prestigiosos expositores invitados

    An谩lisis de los perfiles de investigadores de Panam谩 e indicadores bibliom茅tricos de Google Scholar

    Get PDF
    The objective of this article is to evaluate the visibility of researchers in Panama and the impact of their publications using bibliometric indicators including h-index, i10index and profile citations in Google Scholar Citations (GSC) categorized by gender, institution, and SNI membership. For automatic data collection in GSC we created an algorithm in the R language which extracted 860 profiles from 47 institutions. 25.5% of the profiles had no citation accounting, and 29.5% had an h-index over 5. Of the 14530 studies extracted from the profiles, 49.3% have been cited once, generating 287616 citations. 62% of citations are from studies by 28 researchers. There is visibility for Panamanian researchers in GSC, but only 3.3% provide 62% of citations, with little impact in publications and indexing errors. This suggests a need to create institutional policies to normalize profile creation.El objetivo de este art铆culo es evaluar la visibilidad de los investigadores de Panam谩 y el impacto de sus publicaciones utilizando indicadores bibliom茅tricos como h-index, i10-index y citas de los perfiles en Google Scholar Citations (GSC) categorizados por sexo, instituci贸n, miembro del SNI. Para la recolecci贸n autom谩tica de datos en GSC se cre贸 un algoritmo en el lenguaje R que extrajo 860 perfiles de 47 instituciones, el 25,5% de los perfiles no se contabilizaron citas, el 29,5% tiene un h-index mayor a 5. De los 14.530 trabajos extra铆dos de los perfiles, 49,3% ha sido citado una vez generando 287.616 citas, 62% de las citas son de trabajos de 28 investigadores. Existe visibilidad de los investigadores de Panam谩 en GSC, pero solo el 3,3% aporta el 62% de las citas, poco impacto en las publicaciones y errores de indexaci贸n, esto sugiere crear pol铆ticas institucionales para normalizar la creaci贸n de los perfiles

    Medical decisions concerning the end of life for cancer patients in three Colombian hospitals 鈥 a survey study

    Get PDF
    Background: Cancer patients鈥 end-of-life care may involve complex decision-making processes. Colombia has legislation regarding provision of and access to palliative care and is the only Latin American country with regulation regarding euthanasia. We describe medical end-of-life decision-making practices among cancer patients in three Colombian hospitals. Methods: Cancer patients who were at the end-of-life and attended in participating hospitals were identified. When these patients deceased, their attending physician was invited to participate. Attending physicians of 261 cancer patients (out of 348 identified) accepted the invitation and answered a questionnaire regarding end-of-life decisions: a.) decisions regarding the withdrawal or withholding of potentially life-prolonging medical treatments, b.) intensifying measures to alleviate pain or other symptoms with hastening of death as a potential side effect, and c.) the administration, supply or prescription of drugs with an explicit intention to hasten death. For each question addressing the first two decision types, we asked if the decision was fully or partially made with the intention or consideration that it may hasten the patient鈥檚 death. Results: Decisions to withdraw potentially life-prolonging treatment were made for 112 (43%) patients, 16 of them (14%) with an intention to hasten death. For 198 patients (76%) there had been some decision to not initiate potentially life-prolonging treatment. Twenty-three percent of patients received palliative sedation, 97% of all patients received opioids. Six patients (2%) explicitly requested to actively hasten their death, for two of them their wish was fulfilled. In another six patients, medications were used with the explicit intention to hasten death without their explicit request. In 44% (n聽= 114) of all cases, physicians did not know if their patient had any advance care directives, 26% (n聽= 38) of physicians had spoken to the patient regarding the possibility of certain treatment decisions to hasten death where this applied. Conclusions: Decisions concerning the end of life were common for patients with cancer in three Colombian hospitals, including euthanasia and palliative sedation. Physicians and patients often fail to communicate about advance care directives and potentially life-shortening effects of treatment decisions. Specific end-of-life procedures, patients鈥 wishes, and availability of palliative care should be further investigated.</p

    Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

    No full text
    Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies. Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality. Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42路4% vs 44路2%; absolute difference -1路69 [-9路58 to 6路11] p=0路67; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5-8] vs 6 [5-8] cm H2O; p=0路0011). ICU mortality was higher in MICs than in HICs (30路5% vs 19路9%; p=0路0004; adjusted effect 16路41% [95% CI 9路52-23路52]; p&lt;0路0001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0路80 [95% CI 0路75-0路86]; p&lt;0路0001). Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status
    corecore